Recent Finacing
Recent Raise
CardioDx offers Corus CAD, a sex-specific blood-based 23-gene expression test for assessing likelihood of obstructive coronary artery disease, processed in CLIA-certified Palo Alto laboratory and shipped via sample kits.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors